On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli

被引：0
|
作者：
Haidong Tan
Guoping Dan
Huiying Gong
Lijun Cao
机构：
[1] Chongqing Duotai Company,
[2] Yushui Biopharmaceutical Co.,undefined
[3] Ltd,undefined
来源：
Biotechnology Letters | 2007年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：507 / 507
相关论文
共 50 条
  • [41] Heterogeneous Treatment Effect Of Recombinant Human Interleukin-1 Receptor Antagonist For Human Severe Sepsis
    Meyer, N. J.
    Dunn, T. G.
    Reilly, J. P.
    Palakshappa, J. A.
    Feng, R.
    Christie, J. D.
    Palardy, J. E.
    Opal, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist
    Chi, EY
    Kendrick, BS
    Carpenter, JF
    Randolph, TW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (12) : 2735 - 2748
  • [43] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05): : 1694 - 1697
  • [44] HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST - HIGH-YIELD EXPRESSION IN ESCHERICHIA-COLI AND EXAMINATION OF CYSTEINE RESIDUES
    STEINKASSERER, A
    SOLARI, R
    MOTT, HR
    APLIN, RT
    ROBINSON, CC
    WILLIS, AC
    SIM, RB
    FEBS LETTERS, 1992, 310 (01) : 63 - 65
  • [45] Purification and refolding of human beta-secretase 1 (BACE1) expressed from Escherichia coli for structure determination
    Lin, L
    Strand, J
    Tam, A
    Liu, C
    Svenson, K
    Chopra, R
    Bridges, K
    DiBlasio-Smith, E
    Hsiao, C
    Liu, Y
    PROTEIN SCIENCE, 2004, 13 : 222 - 222
  • [46] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA PRODUCED IN ESCHERICHIA-COLI
    KIKUMOTO, Y
    HONG, YM
    NISHIDA, T
    NAKAI, S
    MASUI, Y
    HIRAI, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (01) : 315 - 321
  • [47] PHARMACOKINETICS, SAFETY AND IMMUNOMODULATORY EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HEALTHY HUMANS
    GRANOWTIZ, EV
    PORAT, R
    MIER, JW
    PRIBBLE, JP
    STILES, DM
    BLOEDOW, DC
    CATALANO, MA
    WOLFF, SM
    DINARELLO, CA
    CYTOKINE, 1992, 4 (05) : 353 - 360
  • [48] Comparison study of recombinant human Interleukin-1 receptor antagonist for treating psoriatic and rheumatoid arthritis
    Ischenko, Alexander
    Kleymenova, Irina
    Raymuev, Kiri
    Solovieva, Liudmila
    Antipova, Tatyana
    Simbirtsev, Andrey
    CYTOKINE, 2010, 52 (1-2) : 22 - 22
  • [49] Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist
    Chang, BS
    Reeder, G
    Carpenter, JF
    PHARMACEUTICAL RESEARCH, 1996, 13 (02) : 243 - 249
  • [50] Anakinra, recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in acute myocardial infarction
    Abbate, Antonio
    Sallourn, Fadi N.
    Straino, Stefania
    Das, Anindita
    Dolbrina, Aldo
    Vecile, Elena
    Houser, Jdn-Erk
    Qureshi, Ian Z.
    Vetrovec, George W.
    Badi, Alfonso
    Kukreja, Rakesh N.
    CIRCULATION, 2007, 116 (16) : 271 - 271
12345